IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 165 filers reported holding IMPAX LABORATORIES INC in Q4 2013. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $182,000 | -3.7% | 14,414 | +1.2% | 0.00% | – |
| Q4 2016 | $189,000 | -98.8% | 14,243 | -97.2% | 0.00% | -100.0% |
| Q1 2016 | $16,287,000 | -19.6% | 508,650 | +7.3% | 0.01% | -27.3% |
| Q4 2015 | $20,269,000 | +28.1% | 474,030 | +5.5% | 0.01% | +22.2% |
| Q3 2015 | $15,820,000 | -99.9% | 449,285 | +5.0% | 0.01% | -10.0% |
| Q2 2015 | $19,657,571,000 | +2.4% | 428,083 | +4.6% | 0.01% | 0.0% |
| Q1 2015 | $19,187,687,000 | +18.8% | 409,381 | -19.7% | 0.01% | +25.0% |
| Q4 2014 | $16,147,518,000 | +112175.9% | 509,707 | -16.0% | 0.01% | 0.0% |
| Q3 2014 | $14,382,000 | -14.6% | 606,600 | +8.1% | 0.01% | -11.1% |
| Q2 2014 | $16,835,000 | -99.8% | 561,363 | +62.5% | 0.01% | +80.0% |
| Q1 2014 | $9,124,940,000 | +3343.7% | 345,380 | +3176.9% | 0.01% | – |
| Q4 2013 | $264,976,000 | – | 10,540 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 5,415,600 | $162,414,000 | 1.91% |
| Broadfin Capital, LLC | 1,217,858 | $36,524,000 | 1.80% |
| NEW AMSTERDAM PARTNERS LLC/NY | 695,100 | $20,846,000 | 1.36% |
| Healthcare Value Capital, LLC | 50,000 | $1,500,000 | 1.26% |
| Iguana Healthcare Management, LLC | 75,000 | $2,249,000 | 1.05% |
| Matarin Capital Management, LLC | 78,292 | $2,347,977,000 | 1.04% |
| Independence Capital Asset Partners, LLC | 253,089 | $7,590,000 | 1.04% |
| Tekla Capital Management LLC | 344,683 | $10,337,000 | 0.95% |
| Penn Capital Management Company, LLC | 794,641 | $23,831,000 | 0.92% |
| Leonard Capital Management, Inc. | 87,661 | $2,629,000 | 0.89% |